首页>
外国专利>
Method of treating chronic hepatic fibrosis comprising administration of zeinmersome nanocarriers
Method of treating chronic hepatic fibrosis comprising administration of zeinmersome nanocarriers
展开▼
机译:治疗慢性肝纤维化的方法,包括施氮钢米载载体
展开▼
页面导航
摘要
著录项
相似文献
摘要
Zeinmersomes (ZMS) comprising zein, a phospholipid and a PEG-polymer are formulated to encapsulate a drug of interest. Olmesartan medoxomil (OM) is encapsulated in the ZMS (OM-ZMS) for oral administration and taken up by the liver where OM diffuses from the ZMS nanocarrier. OM concentrations in liver were at least 8 times higher than that measured in plasma. Established fibrosis was reversed in a thioacetamide-induced rat model of human chronic hepatic fibrosis. The OM-ZMS provides a hepatic drug delivery system that reduces the potential of side-effects caused by OM, including OM-associated sprue-like enteropathy, to treat chronic hepatic fibrosis and associated duodenal changes.
展开▼